Results from the Phase IIb SunRISe-1 study demonstrated a one-year duration of response with the TAR-200 intravesical ...

Although 80% of patients will achieve an initial complete response (CR ... One of those alternatives is removal of the bladder which offers the most definitive cancer treatment; however, it ...

When the cancer invades the muscle or deeper portions of the bladder, the risk of cancer spreading to the lymph nodes is approximately 20 percent. Complete removal of the bladder (cystectomy) is the ...

Johnson & Johnson (NYSE: JNJ) announced today that new data from its leading oncology pipeline will be presented at the American Urological Association (AUA) 2025 Annual Meeting, taking place April 26 ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

The 45% complete response rate exceeds those ... who would otherwise require a full cystectomy, the surgical removal of the urinary bladder. Preventing or delaying cystectomy provides significant ...

A supplemental Biologics License Application has been submitted to the FDA for Anktiva plus BCG in papillary NMIBC.